Immunitybio (IBRX) had the highest return between October 10, 2023 and December 5, 2023 by a mid-cap US stock, returning 164.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 10/10/2023 - 12/5/2023 | 164.75% |
CleanSpark (CLSK) | 10/10/2023 - 12/5/2023 | 154.37% |
Scholar Rock (SRRK) | 10/10/2023 - 12/5/2023 | 115.97% |
TG Therapeutics (TGTX) | 10/10/2023 - 12/5/2023 | 100% |
Gap (GAP) | 10/10/2023 - 12/5/2023 | 98.47% |
Telecom Argentina SA ADR (TEO) | 10/10/2023 - 12/5/2023 | 73.65% |
IREN (IREN) | 10/10/2023 - 12/5/2023 | 71.08% |
Celcuity LLC (CELC) | 10/10/2023 - 12/5/2023 | 66.3% |
Crispr Therapeutics (CRSP) | 10/10/2023 - 12/5/2023 | 65.61% |
Spirit Aerosystems (SPR) | 10/10/2023 - 12/5/2023 | 63.35% |
Madrigal Pharmaceuticals (MDGL) | 10/10/2023 - 12/5/2023 | 63.06% |
StoneCo (STNE) | 10/10/2023 - 12/5/2023 | 62.59% |
Rhythm Pharmaceuticals (RYTM) | 10/10/2023 - 12/5/2023 | 55.84% |
American Superconductor (AMSC) | 10/10/2023 - 12/5/2023 | 54.5% |
Oscar Health (OSCR) | 10/10/2023 - 12/5/2023 | 54.17% |
Arcellx (ACLX) | 10/10/2023 - 12/5/2023 | 53.23% |
HCI (HCI) | 10/10/2023 - 12/5/2023 | 52.95% |
Apellis Pharmaceuticals (APLS) | 10/10/2023 - 12/5/2023 | 51.84% |
TransMedics (TMDX) | 10/10/2023 - 12/5/2023 | 51.41% |
Impinj (PI) | 10/10/2023 - 12/5/2023 | 51.25% |
Viking Therapeutics (VKTX) | 10/10/2023 - 12/5/2023 | 50.17% |
Lemonade (LMND) | 10/10/2023 - 12/5/2023 | 49.83% |
Riot Blockchain (RIOT) | 10/10/2023 - 12/5/2023 | 49.46% |
Kymera Therapeutics (KYMR) | 10/10/2023 - 12/5/2023 | 49.02% |
F&G Annuities & Life (FG) | 10/10/2023 - 12/5/2023 | 48.48% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
